Microtrac MRB and Colloid Metrix GmbH announce that effective February 15th, 2022 Microtrac MRB has acquired the STABINO™ product line from Colloid Metrix. The STABINO™ has been established as a worldwide standard for the measurement of zeta potential and stability in suspensions and emulsions for many years. “We are excited to continue this great legacy”... Read more
Already used in Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) for adult patients, Rapiscan is now approved for use in stress Cardiac Magnetic Resonance Imaging (CMR) Rapiscan, a pharmacological stress agent, is an alternative for patients who cannot exercise Chalfont St Giles, UK – 14 February 2022 – GE Healthcare has announced that... Read more
While many microscopists work in research, clinical or educational settings, there is also a small group who spend their spare time enjoying microscopy as a hobby. Quite a few submissions for our ZEISS Microscopy Image Contest 2021 came from hobby microscopists. Enjoy their beautiful images and thoughts on microscopy as a hobby: Michael Witzke, Germany... Read more
BOSTON – February 14, 2022 – GE (NYSE: GE) announced the appointment of Frank Jimenez as Vice President & General Counsel of GE Healthcare effective February 21, 2022. In this role, Frank will be responsible for GE Healthcare’s Global Law and Policy teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Frank’s proven leadership... Read more
BOSTON – February 14, 2022 – GE (NYSE: GE) announced the appointment of Frank Jimenez as Vice President & General Counsel of GE Healthcare effective February 21, 2022. In this role, Frank will be responsible for GE Healthcare’s Global Law and Policy teams. Pete Arduini, chief executive officer of GE Healthcare, said, “Frank’s proven leadership... Read more
WHO’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoActemra for people with COVID-19 in low- and middle-income countries Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra, as recommended in global treatment guidelines Twelfth Roche medicine or test to be... Read more
Q4 2021 revenues $683.5M, up 8.9% year-over-year (yoy); organic revenue growth of 11.4% yoy Q4 2021 GAAP EPS $0.50; non-GAAP EPS $0.59, up $0.01 yoy FY 2021 revenues of $2.42B, up 21.7% yoy; organic revenue growth of 19.1% yoy FY 2021 GAAP EPS $1.81; non-GAAP EPS $2.10, up 55.6% yoy Solid organic revenue and non-GAAP... Read more
In the YOSEMITE and RHINE studies in diabetic macular edema, at least 60% of eligible Vabysmo patients could extend treatment to every four months at two years, compared to 50% at year one Almost 80% of eligible Vabysmo patients could extend treatment to every three months or longer in both studies In the Archway study... Read more